Bio-Reference Laboratories Company Profile (NASDAQ:BRLI)

About Bio-Reference Laboratories

Bio-Reference Laboratories logoBio-Reference Laboratories, Inc. is a clinical testing laboratory, which offers testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. The Company offers a range of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. It is focused on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional health care. It offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology and other tissue analysis. It operates a clinical knowledge management service through its PSIMedica business unit. It also operates a Web-based connectivity portal solution for laboratories and physicians through its CareEvolve subsidiary. Its laboratory testing business consists of routine testing and esoteric testing.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Health Care Services
  • Exchange: NASDAQ
  • Symbol: BRLI
  • CUSIP: 09057G60
Key Metrics:
  • Previous Close: $34.61
  • 50 Day Moving Average: $41.81
  • 200 Day Moving Average: $36.97
  • 52-Week Range: $26.32 - $47.49
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 14.98
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:
Companies Related to Bio-Reference Laboratories:

Analyst Ratings

Consensus Ratings for Bio-Reference Laboratories (NASDAQ:BRLI) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Bio-Reference Laboratories (NASDAQ:BRLI)
No equities research coverage for this company has been tracked by


Earnings History for Bio-Reference Laboratories (NASDAQ:BRLI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
6/8/2015Q215$0.44$0.38$227.33 million$224.00 millionViewListenView Earnings Details
3/5/2015Q115$0.36$0.24$216.40 million$209.00 millionViewListenView Earnings Details
12/18/2014Q414$0.63$0.69$228.81 million$227.60 millionViewListenView Earnings Details
8/27/2014Q314$0.53$0.55$210.44 million$222.10 millionViewListenView Earnings Details
6/5/2014Q214$0.32$0.37$0.20 million$201.30 millionViewListenView Earnings Details
3/4/2014Q114$0.15$0.11$175.52 million$181.30 millionViewListenView Earnings Details
12/19/2013Q4$0.55$0.40$188.96 million$192.20 millionViewListenView Earnings Details
8/29/2013Q3 2013$0.51$0.53$183.50 million$185.40 millionViewListenView Earnings Details
6/6/2013Q2 2013$0.41$0.41$176.04 million$176.50 millionViewListenView Earnings Details
2/28/2013Q1 2013$0.28$0.31$165.44 million$161.30 millionViewListenView Earnings Details
12/6/20120.46$0.46$175.46 millionViewListenView Earnings Details
8/30/2012Q312$0.43$0.45$0.17 million$0.17 millionViewN/AView Earnings Details
6/7/2012$0.32$0.33ViewN/AView Earnings Details
3/1/2012$0.21$0.26ViewN/AView Earnings Details
12/8/2011$0.35$0.37ViewN/AView Earnings Details
8/25/2011$0.34$0.36ViewN/AView Earnings Details
5/26/2011$0.24$0.26ViewN/AView Earnings Details
3/3/2011$0.17$0.28ViewN/AView Earnings Details
12/16/2010$0.30$0.31$124.19 million$126.60 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Bio-Reference Laboratories (NASDAQ:BRLI)
Current Year EPS Consensus Estimate: $1.98 EPS
Next Year EPS Consensus Estimate: $2.31 EPS


Dividend History for Bio-Reference Laboratories (NASDAQ:BRLI)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Bio-Reference Laboratories (NASDAQ:BRLI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/13/2013Howard DubinettCOOSell20,000$29.40$588,000.00View SEC Filing  
6/27/2013Sam SingerCFOSell4,000$28.95$115,800.00View SEC Filing  
6/26/2013Sam SingerCFOSell6,000$28.50$171,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Bio-Reference Laboratories (NASDAQ:BRLI)
News IconBioReference Laboratories, Inc. BRLI Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:BRLI) - November 23 at 10:00 PM
News IconBioReference Laboratories, Inc. BRLI Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:BRLI) - November 20 at 8:01 AM logoWhy Britain's NHS Is Great, Despite Its Dire Financial Situation (NASDAQ:BRLI) - August 26 at 3:53 PM logoOpko Is a Buying Opportunity After FDA's Approval of Kidney Drug (NASDAQ:BRLI) - June 30 at 5:15 PM logoHow Risky Is Opko Health Inc. Stock? (NASDAQ:BRLI) - March 18 at 4:19 PM logo3 Predictions for Opko Health Inc. in 2016 (NASDAQ:BRLI) - December 5 at 9:03 AM logoOpko Health Reports a Surprise Profit -- Were Investors Right to Cheer? (NASDAQ:BRLI) - November 19 at 7:57 AM logoOPKO Health Refinances Bio-Reference Laboratories Credit Facility (NASDAQ:BRLI) - November 6 at 11:34 AM logoOpko Health Has Crashed 55% In Three Months; Time To Buy? (NASDAQ:BRLI) - September 28 at 10:44 AM logoWhy Insiders Are Buying Opko Health, Inc. Stock (NASDAQ:BRLI) - September 24 at 10:24 AM logoOPKO HELATH, INC. Financials (NASDAQ:BRLI) - August 25 at 1:04 PM logoInnospec Set to Join the S&P SmallCap 600 (NASDAQ:BRLI) - August 20 at 6:38 PM logoBIO REFERENCE LABORATORIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisit (NASDAQ:BRLI) - August 20 at 5:05 PM logoOPKO Completes Acquisition of Bio-Reference Laboratories (NASDAQ:BRLI) - August 20 at 11:06 AM logoBIO REFERENCE LABORATORIES INC Files SEC form 8-K, Other Events (NASDAQ:BRLI) - August 10 at 5:08 PM logoOPKO's Prostate Cancer Hit (NASDAQ:BRLI) - July 23 at 8:59 AM logoOPKO and Bio-Reference Laboratories Announce Early Termination of the Waiting Period for Planned Acquisition (NASDAQ:BRLI) - July 5 at 1:05 AM logoBarron's Recap: Airline Stocks Ready To Soar (NASDAQ:BRLI) - June 21 at 7:13 PM logoBRLI INVESTOR ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Bio-Reference Laboratories, Inc. Concerning the Sale of the Company to Opko Health Inc. (NASDAQ:BRLI) - June 16 at 11:44 AM


What is Bio-Reference Laboratories' stock symbol?

Bio-Reference Laboratories trades on the NASDAQ under the ticker symbol "BRLI."

When will Bio-Reference Laboratories announce their earnings?

Bio-Reference Laboratories is scheduled to release their next quarterly earnings announcement on Tuesday, August, 25th 2015.

How do I buy Bio-Reference Laboratories stock?

Shares of Bio-Reference Laboratories can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Bio-Reference Laboratories stock cost?

One share of Bio-Reference Laboratories stock can currently be purchased for approximately $34.61.

Bio-Reference Laboratories (NASDAQ:BRLI) Chart for Wednesday, February, 22, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Bio-Reference Laboratories (NASDAQ:BRLI)

Earnings History Chart

Earnings by Quarter for Bio-Reference Laboratories (NASDAQ:BRLI)

Dividend History Chart

Dividend Payments by Quarter for Bio-Reference Laboratories (NASDAQ:BRLI)

Last Updated on 2/22/2017 by Staff